Hengehold Capital Management LLC Pfizer Inc Transaction History

Hengehold Capital Management LLC

$1.05 Billion
Q3 2024

A detailed history of Hengehold Capital Management LLC transactions in Pfizer Inc stock. As of the latest transaction made, Hengehold Capital Management LLC holds 117,803 shares of PFE stock, worth $3.05 Million. This represents 0.32% of its overall portfolio holdings.

Number of Shares

117,803

Previous 110,500 6.61%

Holding current value

$3.05 Million

Previous $3.09 Million 10.29%

% of portfolio

0.32%

Previous 0.32%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 16, 2024	BUY	$27.7 - $31.39 $202,293 - $229,241	7,303 Added 6.61%	117,803 $3.41 Million
Q2 2024 Jul 16, 2024	SELL	$25.26 - $29.6 $146,204 - $171,324	-5,788 Reduced 4.98%	110,500 $3.09 Million
Q1 2024 Apr 15, 2024	BUY	$25.89 - $29.73 $583,431 - $669,965	22,535 Added 24.04%	116,288 $3.23 Million
Q4 2023 Jan 19, 2024	SELL	$26.13 - $33.94 $47,765 - $62,042	-1,828 Reduced 1.91%	93,753 $2.7 Million
Q3 2023 Oct 13, 2023	BUY	$32.09 - $37.51 $74,127 - $86,648	2,310 Added 2.48%	95,581 $3.17 Million
Q2 2023 Jul 17, 2023	SELL	$36.12 - $41.79 $24,778 - $28,667	-686 Reduced 0.73%	93,271 $3.42 Million
Q1 2023 Apr 19, 2023	SELL	$39.39 - $51.28 $10,280 - $13,384	-261 Reduced 0.28%	93,957 $3.83 Million
Q4 2022 Jan 19, 2023	BUY	$41.75 - $54.5 $86,673 - $113,142	2,076 Added 2.25%	94,218 $0
Q3 2022 Oct 21, 2022	BUY	$43.76 - $53.42 $15,316 - $18,697	350 Added 0.38%	92,142 $4.03 Million
Q2 2022 Jul 22, 2022	BUY	$46.53 - $55.17 $40,713 - $48,273	875 Added 0.96%	91,792 $4.81 Million
Q1 2022 Apr 27, 2022	SELL	$45.75 - $56.69 $13,587 - $16,836	-297 Reduced 0.33%	90,917 $4.71 Million
Q4 2021 Feb 02, 2022	SELL	$41.32 - $61.25 $26,899 - $39,873	-651 Reduced 0.71%	91,214 $5.39 Million
Q3 2021 Nov 03, 2021	SELL	$39.25 - $50.42 $68,138 - $87,529	-1,736 Reduced 1.85%	91,865 $3.95 Million
Q2 2021 Aug 04, 2021	BUY	$35.91 - $40.68 $28,225 - $31,974	786 Added 0.85%	93,601 $3.67 Million
Q1 2021 Apr 30, 2021	BUY	$33.49 - $37.77 $246,988 - $278,553	7,375 Added 8.63%	92,815 $3.36 Million
Q4 2020 Feb 09, 2021	BUY	$33.47 - $42.56 $46,489 - $59,115	1,389 Added 1.65%	85,440 $3.15 Million
Q3 2020 Nov 09, 2020	BUY	$31.75 - $37.25 $4,349 - $5,103	137 Added 0.16%	84,051 $3.09 Million
Q2 2020 Jul 31, 2020	SELL	$30.12 - $36.54 $105,450 - $127,926	-3,501 Reduced 4.01%	83,914 $2.74 Million
Q1 2020 Apr 22, 2020	SELL	$27.03 - $38.62 $66,169 - $94,541	-2,448 Reduced 2.72%	87,415 $2.85 Million
Q4 2019 Jan 24, 2020	BUY	$32.92 - $37.36 $85,328 - $96,837	2,592 Added 2.97%	89,863 $3.52 Million
Q3 2019 Oct 22, 2019	BUY	$32.49 - $42.13 $4,873 - $6,319	150 Added 0.17%	87,271 $3.14 Million
Q2 2019 Jul 23, 2019	BUY	$36.98 - $41.52 $178,465 - $200,375	4,826 Added 5.86%	87,121 $3.77 Million
Q1 2019 Apr 30, 2019	BUY	$37.5 - $41.2 $70,837 - $77,826	1,889 Added 2.35%	82,295 $3.5 Million
Q4 2018 Jan 22, 2019	SELL	$38.47 - $43.86 $11,964 - $13,640	-311 Reduced 0.39%	80,406 $3.51 Million
Q3 2018 Oct 23, 2018	SELL	$34.47 - $41.81 $117,439 - $142,446	-3,407 Reduced 4.05%	80,717 $3.56 Million
Q2 2018 Jul 20, 2018	BUY	$32.98 - $35.16 $365,583 - $389,748	11,085 Added 15.18%	84,124 $3.05 Million
Q1 2018 Apr 17, 2018	BUY	$31.91 - $37.02 $36,217 - $42,017	1,135 Added 1.58%	73,039 $2.59 Million
Q4 2017 Jan 26, 2018	BUY	$33.26 - $35.29 $7,516 - $7,975	226 Added 0.32%	71,904 $2.6 Million
Q3 2017 Oct 17, 2017	BUY	$31.0 - $34.15 $2.22 Million - $2.45 Million	71,678	71,678 $2.56 Million

Others Institutions Holding PFE

# of Institutions

3,261

Shares Held

3.62B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $145B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hengehold Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hengehold Capital Management LLC with notifications on news.

Account

Hengehold Capital Management LLC Pfizer Inc Transaction History